Harbor Osmosis国际资源效率主动型ETF EFFI 深 沪
等待开盘 04-02 09:30:00 美东时间
24.0607
+0.346
+1.46%
华盛通- 最 高24.0607
- 今 开23.7144
- 成交量 88股
- 最 低 24.0607
- 昨 收 23.7144
- 总市值 1.36亿
- 52周最高 25.5079
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 18.7954
- 委 比 0.00%
- 总股本 565.00万
- 历史最高 25.5079
- 量 比 0.22
- 振 幅 0.00%
- 历史最低 17.0723
- 每 手 1
- 风险率 1.69%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Rademikibart Demonstrates Best-In-Class Potential In Phase 3 Atopic Dermatitis Study
BRIEF-Rademikibart Demonstrates Best-In-Class Potential In Phase 3 Atopic Dermatitis Study March 30 (Reuters) - Connect Biopharma Holdings Ltd CNTB.O : RADEMIKIBART DEMONSTRATES BEST-IN-CLASS POTENTIAL IN PHASE 3 ATOPIC DERMATITIS STUDY CONNECT BIOPHARMA HOLDINGS LTD - RADEMIKIBART ACHIEVES RAPID, D
03-30 21:20
BRIEF-Sanofi’s Sarclisa Subcutaneous Formulation Via On-Body Injector Recommended For EU Approval
BRIEF-Sanofi’s Sarclisa Subcutaneous Formulation Via On-Body Injector Recommended For EU Approval March 27 (Reuters) - Sanofi SA SASY.PA : SANOFI’S SARCLISA SUBCUTANEOUS FORMULATION ADMINISTERED VIA ON-BODY INJECTOR RECOMMENDED FOR EU APPROVAL BY THE CHMP TO TREAT MULTIPLE MYELOMA IF APPROVED, SARCL
03-27 20:03
SENSETIME(20HK):FY25 RESULTS BEAT ON SOLID GEN AI BUSINESS AND ENHANCED OPERATING EFFICIENCY
SenseTime announced FY25 results: total revenue grew by 33% YoY to RMB5.01bn, 3...
03-25 09:57
BRIEF-Pfizer Says LB6V Vaccine Candidate Was Well Tolerated With No Safety Concerns Identified At Time Of Analysis
BRIEF-Pfizer Says LB6V Vaccine Candidate Was Well Tolerated With No Safety Concerns Identified At Time Of Analysis March 23 (Reuters) - Pfizer Inc PFE.N : PFIZER: LB6V VACCINE CANDIDATE WAS WELL TOLERATED WITH NO SAFETY CONCERNS IDENTIFIED AT TIME OF ANALYSIS PFIZER: CO & VALNEVA ANNOUNCE LYME DISEA
03-23 18:45
BRIEF-Mediaco Appoints Armando Diaz As Vice President, Operations & Efficiency
BRIEF-Mediaco Appoints Armando Diaz As Vice President, Operations & Efficiency March 16 (Reuters) - Mediaco Holding Inc MDIA.O : MEDIACO APPOINTS ARMANDO DIAZ AS VICE PRESIDENT, OPERATIONS & EFFICIENCY Source text: ID:nBwbD63q7a Further company coverage: MDIA.O (( Reuters.Briefs@thomsonreuters.com ;
03-16 20:12
BRIEF-Centrus, Palantir Partner to Boost Efficiency in US Uranium Enrichment Expansion
BRIEF-Centrus, Palantir Partner to Boost Efficiency in US Uranium Enrichment Expansion March 12 (Reuters) - Centrus Energy Corp LEU.N : CENTRUS PARTNERS WITH PALANTIR TO DRIVE COST SAVINGS AND UNLOCK OPERATIONAL EFFICIENCIES IN MAJOR EXPANSION OF U.S. URANIUM ENRICHMENT CAPACITY Source text: ID:nPn2
03-12 19:20
Verano Q4 revenue slightly beats on retail gains
Verano Q4 revenue slightly beats on retail gains Overview U.S. cannabis operator's Q4 revenue slightly beat analyst expectations, up 2% sequentially Q4 adjusted EBITDA was a slight miss versus consensus Company closed $195 mln credit facility to refinance debt at lower rates Outlook Verano expects 2
03-12 19:10
CORRECTED-Infinity Natural Resources Q4 net income rises amid surge in output growth
CORRECTED-Infinity Natural Resources Q4 net income rises amid surge in output growth Corrects to add temporal context to the asset acquisition in Overview and removes it from Result Drivers Overview U.S. oil and gas producer's Q4 net income rose sharply on 93% production growth Adjusted EBITDAX for
03-11 04:51
UPDATE 3-Axel Springer buys UK's Telegraph for $766 million, ending ownership limbo
UPDATE 3-Axel Springer buys UK's Telegraph for $766 million, ending ownership limbo Axel Springer aims to preserve Telegraph's legacy and character RedBird IMI praises Axel Springer's commercial offer UK regulatory scrutiny continues Adds further details throughout, statement from Axel Springer's CE
03-06 20:04
Toro beats Q1 sales, adjusted profit expectations, lifts annual sales forecast
Toro beats Q1 sales, adjusted profit expectations, lifts annual sales forecast Overview Outdoor solutions provider's fiscal Q1 net sales rose 4%, beating analyst expectations Adjusted EPS for fiscal Q1 rose 14% yr/yr, beating analyst expectations Company raised full-year guidance for net sales and E
03-05 21:42
